Vincent Jongkind

Vincent Jongkind

Auto-generated profile, based on publicly available information

Vincent Jongkind

Department of Surgery, Amsterdam University Medical Center, University of Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
MBMartin Björck
Martin Björck
JEJonothan J Earnshaw
Jonothan J Earnshaw
SAStefan Acosta
Stefan Acosta
FGFrederico Bastos Gonçalves
Frederico Bastos Gonçalves
FCFrederic Cochennec
Frederic Cochennec
KRKumud Rai
Kumud Rai

1 November 2010 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
VJVincent Jongkind
Vincent Jongkind
GAGeorge J.M. Akkersdijk
George J.M. Akkersdijk
KYKak K. Yeung
Kak K. Yeung
WWWillem Wisselink
Willem Wisselink

1 August 2019 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
DLDaniël P V Lambrichts
Daniël P V Lambrichts
SVSandra Vennix
Sandra Vennix
GMGijsbert D Musters
Gijsbert D Musters
IMIrene M Mulder
Irene M Mulder
HSHilko A Swank
Hilko A Swank
Stefaan NijsStefaan Nijs
Stefaan Nijs

1 September 2010 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
VJVincent Jongkind
Vincent Jongkind
KYKak K. Yeung
Kak K. Yeung
GAGeorge J.M. Akkersdijk
George J.M. Akkersdijk
DHDavid Heidsieck
David Heidsieck
JRJohannes B. Reitsma
Johannes B. Reitsma
WWWillem Wisselink
Willem Wisselink

1 July 2012 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
MLMatteus A.M. Linsen
Matteus A.M. Linsen
VJVincent Jongkind
Vincent Jongkind
DNDenise Nio
Denise Nio
AHArjan W.J. Hoksbergen
Arjan W.J. Hoksbergen
WWWillem Wisselink
Willem Wisselink

6 September 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
VJVincent Jongkind
Vincent Jongkind
JEJonothan J. Earnshaw
Jonothan J. Earnshaw
FGFrederico Bastos Gonçalves
Frederico Bastos Gonçalves
FCFrederic Cochennec
Frederic Cochennec
EDE. Sebastian Debus
E. Sebastian Debus
MBMartin Björck
Martin Björck
To perform a scoping review of how patients with COVID-19 are affected by acute limb ischaemia (ALI) and evaluate the recommendations of the 2020 ESVS ALI Guidelines for these patients. Research questions were defined, and a systematic literature search was performed following the PRISMA guidelines. Abstracts and unpublished literature were not included. The definition of ALI in this review is in accordance with the ESVS guidelines. Most identified papers were case reports or case series, although population based data and data from randomised controlled trials were also identified. In total, 114 unique and relevant papers were retrieved. Data were conflicting concerning whether the incidence of ALI increased, or remained unchanged, during the pandemic. Case reports and series reported ALI in patients who were younger and healthier than usual, with a greater proportion affecting the upper limb. Whether or not this is coincidental remains uncertain. The proportion of men/women affected seems unchanged. Most reported cases were in hospitalised patients with severe COVID-19. Patients with ALI as their first manifestation of COVID-19 were reported. Patients with ALI have a worse outcome if they have a simultaneous COVID-19 infection. High levels of D-dimer may predict the occurrence of arterial thromboembolic events in patients with COVID-19. Heparin resistance was observed. Anticoagulation should be given to hospitalised COVID-19 patients in prophylactic dosage. Most of the treatment recommendations from the ESVS Guidelines remained relevant, but the following were modified regarding patients with COVID-19 and ALI: 1) CTA imaging before revascularisation should include the entire aorta and iliac arteries; 2) there should be a high index of suspicion, early testing for COVID-19 infection and protective measures are advised; and 3) there should be preferential use of local or locoregional anaesthesia during revascularisation. Although the epidemiology of ALI has changed during the pandemic, the recommendations of the ESVS ALI Guidelines remain valid. The above mentioned minor modifications should be considered in patients with COVID-19 and ALI.